Recent clinical trials in Australia
Sirius Therapeutics: Feb 2024
Sirius Therapeutics Begins Phase 1 Clinical Trial in Australia, of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders.
- Sirius HP
Ji XING Pharmaceuticals Limited: Feb 2024
JI XING Announces First Subject Successfully Dosed in Australian Phase I Clinical Trial of JX09.